Early diagnosis of Alzheimer's disease: is MCI too late?
about
Brain fuel metabolism, aging, and Alzheimer's diseaseThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionThe Alzheimer's disease neuroimaging initiative: progress report and future plansAlzheimer disease: are we intervening too late?Impaired long distance functional connectivity and weighted network architecture in Alzheimer's disease.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.The Sub-Classification of Amnestic Mild Cognitive Impairment Using MRI-Based Cortical Thickness Measures.Improving Dual-Task Walking Paradigms to Detect Prodromal Parkinson's and Alzheimer's Diseases.Smoking and increased Alzheimer's disease risk: a review of potential mechanismsA comprehensive assessment of resting state networks: bidirectional modification of functional integrity in cerebro-cerebellar networks in dementia.The spectrum of cognitive impairment in Lewy body diseasesThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustmentNovel ThickNet features for the discrimination of amnestic MCI subtypes.MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurementsHow Do Persons with Mild Acquired Cognitive Impairment Use Information and Communication Technology and E-Services? Results from a Swedish National SurveyThe Framingham Brain Donation Program: neuropathology along the cognitive continuum.Distinct Changes in Functional Connectivity in Posteromedial Cortex Subregions during the Progress of Alzheimer's Disease.The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled TrialDetection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers.Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.Validity, reliability, and feasibility of clinical staging scales in dementia: a systematic review.Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.Retrograde Amnesia for Episodic and Semantic Memories in Amnestic Mild Cognitive Impairment.Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease.Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.The value of whole-brain CT perfusion imaging and CT angiography using a 320-slice CT scanner in the diagnosis of MCI and AD patients.Time Orientation and 10 Years Risk of Dementia in Elderly Adults: The Three-City Study.Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.Visualizing Hyperactivation in Neurodegeneration Based on Prefrontal Oxygenation: A Comparative Study of Mild Alzheimer's Disease, Mild Cognitive Impairment, and Healthy ControlsInterplay between protein glycosylation pathways in Alzheimer's disease.Slowing and Loss of Complexity in Alzheimer's EEG: Two Sides of the Same Coin?Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment.Significant junctures on the way towards becoming a user of assistive technology in Alzheimer's disease.Clinical utility of the hopkins Verbal Test-Revised for detecting Alzheimer's disease and mild cognitive impairment in Spanish population.Association between Sleep Disordered Breathing and Nighttime Driving Performance in Mild Cognitive Impairment.Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.Mild cognitive impairment and progression to dementia of Alzheimer's disease.
P2860
Q24625859-0BD89271-5466-4D3B-918A-FD603ACB03F4Q27006831-D103DA45-8EBC-4E21-9F54-6B8033C3F19DQ28749585-A00AD3CD-CC17-4E43-824A-7E3962E224CCQ29036834-0F8942AF-821A-4E23-A95A-8BED6EABC6D0Q30596643-ED6E2B10-12E5-4886-A8DA-2AFBC3087BB6Q30971403-0606918D-DD86-4750-98C7-ECD1540816F6Q33659817-5FA047F4-71CB-44B2-8DB1-93A95EF0A194Q33710775-EC7A29C9-6856-48BA-95A1-D86FDF4B486EQ33902721-BB9FC532-EACD-42A9-9629-B44C7D544F04Q33972506-9E127AE3-04C9-4295-A749-29B47ED3E039Q34019751-132576AF-E7D9-4827-9163-9D013FBCF17AQ34065449-EAFF2FE7-F5CA-4080-8D53-1F8C7A414613Q34163448-6F3B24B9-329A-43E7-AC4D-395ED9BC1E4DQ34431841-18FF9D8C-E4C5-4A03-8233-63F1E9270679Q34770643-36724CA9-DA02-45A8-B142-B6681BC1DF2BQ36079866-26908FE4-C976-45FC-9D00-2EF89B797F94Q36755746-B55CFD5B-C9C4-424D-A95C-604EA9D934C6Q36789198-E17A075A-430A-450A-B287-2164F2F4E81EQ36829198-A911B83A-DA28-432A-848F-9D513256EECAQ36934163-3AD31B1E-CB0A-4EA5-9352-BFD8BEE8B3DAQ37326829-C710494B-4079-42A9-84DF-31316C17035CQ37931549-BA405490-A6FC-4BD1-84D3-1D640D4BDE6FQ37947984-A7E85FE1-B4D0-4CBD-93E9-399A16B0FCF0Q38375812-FAEF8160-132A-44E3-B826-09C100FB91D4Q38654257-3C55B8D2-8696-4F2A-ABFE-D3B212A2825CQ38690145-573EA156-1589-47C5-813F-0BB8F85235ABQ38747251-FE0A7055-56F2-4AD5-ADB4-DEFD1A333D92Q40660994-B8C9C0B4-2793-4540-A80C-0494233EB286Q41205194-BFA6FEB8-5CFB-465A-B6F8-70066FC2A385Q41458145-68FA6EAE-2379-4C34-B0DA-8E0B78333831Q41623625-E30668A1-F6B1-4377-9B53-D64230AFACF8Q41723383-5C053F20-5F90-4E67-BECA-6EC53F6BBEACQ41960933-33646536-863B-416F-A4B3-32D0A8D5DAA9Q43604874-9C28F137-F77A-4AE7-84A4-4716E3DC306AQ44140585-BB8B9C67-AB43-4295-8F2E-66945BAEF7FDQ45995023-3D1174D6-ACBD-46B2-B3E1-977F56EBFBC4Q47739016-0544659F-C820-4FFC-A8F8-2F530708E825Q47784298-C0DE8942-AC1F-4F49-960B-59DFBADE9A1AQ47833026-6C4EDAD9-2E7B-4F96-8D4B-6FDE0CCB0041Q47915428-2459C40A-FB45-44F1-82E9-F558C64BE004
P2860
Early diagnosis of Alzheimer's disease: is MCI too late?
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Early diagnosis of Alzheimer's disease: is MCI too late?
@ast
Early diagnosis of Alzheimer's disease: is MCI too late?
@en
Early diagnosis of Alzheimer's disease: is MCI too late?
@nl
type
label
Early diagnosis of Alzheimer's disease: is MCI too late?
@ast
Early diagnosis of Alzheimer's disease: is MCI too late?
@en
Early diagnosis of Alzheimer's disease: is MCI too late?
@nl
prefLabel
Early diagnosis of Alzheimer's disease: is MCI too late?
@ast
Early diagnosis of Alzheimer's disease: is MCI too late?
@en
Early diagnosis of Alzheimer's disease: is MCI too late?
@nl
P2860
P1476
Early diagnosis of Alzheimer's disease: is MCI too late?
@en
P2860
P304
P356
10.2174/156720509788929237
P577
2009-08-01T00:00:00Z